Methocarbamol and Dysphemia - a phase IV clinical study of FDA data

Summary:

Dysphemia is reported as a side effect among people who take Methocarbamol (methocarbamol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gabapentin, and have Complex regional pain syndrome.

The phase IV clinical study analyzes which people have Dysphemia when taking Methocarbamol. It is created by eHealthMe based on reports of 16,788 people who have side effects when taking Methocarbamol from the FDA, and is updated regularly.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.

What is Dysphemia?

Dysphemia (stammering or stuttering) is found to be associated with 506 drugs and 554 conditions by eHealthMe. Check the latest studies of Dysphemia.

On Aug, 04, 2026

16,788 people reported to have side effects when taking Methocarbamol.
Among them, 17 people (0.1%) have Dysphemia.

Among these 17 people:

How long have people been on Methocarbamol when they have Dysphemia? *

What is the gender of people who have Dysphemia when taking Methocarbamol? *

female: 86.67 %
male: 13.33 %

What is the age of people who have Dysphemia when taking Methocarbamol? *

What are other drugs people take besides Methocarbamol? *

What are other side effects people have besides Dysphemia? *

Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 5 people, 29.41%
Memory Loss: 5 people, 29.41%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 29.41%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 23.53%
Depression: 4 people, 23.53%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 17.65%
Disturbance In Attention: 3 people, 17.65%
Speech Disorder: 3 people, 17.65%
Confusional State: 3 people, 17.65%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 29.41%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 5 people, 29.41%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 17.65%
Uveitis (inflammation of the uvea): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
High Blood Pressure: 2 people, 11.76%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 11.76%
Migraine (headache): 1 person, 5.88%
Ill-Defined Disorder: 1 person, 5.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and have Dysphemia?

- Check whether Dysphemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methocarbamol:

Methocarbamol (17,766 reports)

Dysphemia treatments and more:

Dysphemia (5,151 reports)

Browse all side effects of Methocarbamol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysphemia:

Dysphemia (506 drugs)

Browse all the conditions that are associated with Dysphemia:

Dysphemia (554 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol (the active ingredients of Methocarbamol) and Methocarbamol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.